Atreca Appoints Leading Cancer Clinical Researcher Lawrence Fong, M.D., As A Technical Advisor
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today the appointment of Lawrence Fong, M.D., as a technical Advisor. Dr. Fong is a world-leading researcher and oncology expert who has dedicated his career to advancing new cancer immunotherapies.